Form 4 for VRTX Vertex Pharmaceuticals
Accepted 2023-02-24 00:00:00 ET · period of report 2023-02-22 · accession 0001209191-23-012672 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-02-24 | 2023-02-22 | VRTX | Arbuckle Stuart A | EVP, COO | S - Sale | $294.33 | -2,401 | 66.3K | -3% | -$706.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-22 | S | D | 394 | $295.38 | 66,504 | D | — | — | (F6) Open market sales reported on this line occurred at a weighted average price of $295.38 (range $294.83 to $295.72). (F2) Mr. Arbuckle undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. |
| 2 | Common | Common Stock | 2023-02-22 | S | D | 1,378 | $294.29 | 66,898 | D | — | — | (F5) Open market sales reported on this line occurred at a weighted average price of $294.29 (range $293.83 to $294.82). (F2) Mr. Arbuckle undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. |
| 3 | Common | Common Stock | 2023-02-22 | S | D | 300 | $292.86 | 68,276 | D | — | — | (F4) Open market sales reported on this line occurred at a weighted average price of $292.86 (range $292.44 to $293.37). (F2) Mr. Arbuckle undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. |
| 4 | Common | Common Stock | 2023-02-22 | S | D | 129 | $291.84 | 68,576 | D | — | — | (F3) Open market sales reported on this line occurred at a weighted average price of $291.84 (range $291.17 to $292.03). (F2) Mr. Arbuckle undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. |
| 5 | Common | Common Stock | 2023-02-22 | S | D | 200 | $296.31 | 66,304 | D | — | — | (F2) Mr. Arbuckle undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. (F7) Open market sales reported on this line occurred at a weighted average price of $296.31 (range $296.20 to $296.41). |